Loading...
Market
New study on AstraZeneca vaccine safety for pregnancy published by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Scientific journals and publications
Story
Family of Pregnant Woman Who Died Post-AstraZeneca Vaccine to Receive Over R$ 1 Million
Dec 7, 2024, 02:29 PM
The family of Thais Possati, a 35-year-old woman who was 23 weeks pregnant when she died shortly after receiving the AstraZeneca Covid-19 vaccine in April 2021, will receive over R$ 1 million in compensation. AstraZeneca has admitted that the vaccine was not tested on pregnant women. This case has raised concerns about the safety of vaccines for pregnant individuals, especially as the CDC recently recommended a novel Hepatitis B vaccine during pregnancy despite limited studies on its effects, including a retrospective cohort study of 75 women and a rat study.
View original story
Similar markets
Yes • 50%
No • 50%
No changes recommended • 25%
Some vaccines recommended for elimination • 25%
Enhanced safety protocols recommended • 25%
Comprehensive overhaul of vaccine policies • 25%
No issues found • 25%
Minor issues found • 25%
Significant issues found • 25%
Undetermined • 25%
Vaccines deemed safe • 25%
Vaccines require modification • 25%
Vaccines deemed unsafe • 25%
No consensus reached • 25%
Confirms higher SAE rate in early batches • 25%
Confirms no difference in SAE rates • 25%
Finds other contributing factors • 25%
Inconclusive results • 25%
CDC • 25%
WHO • 25%
NIH • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No contamination detected • 25%
Low levels of plasmid DNA detected • 25%
Moderate levels of plasmid DNA detected • 25%
High levels of plasmid DNA detected • 25%